Risks of suicidality in adult patients with epilepsy

Table 5 Significance between patients and control subjects in the concentrations of serotonin, catecholamines and dopamine in relation to epilepsy itself- and its treatment-related variables regardless to the presence or absence of suicidality

Epilepsy-related variables	Serotonin	Noradrenaline	Adrenaline	Dopamine
Type of epilepsy
Generalized
P1	0.002	0.016	0.0001	0.051
Focal
P1	0.017	0.007	0.0001	0.558
P2	0.176	0.305	0.662	0.096
Focal epilepsies
Frontal
P1	0.074	0.032	0.0001	0.469
Temporal
P1	0.003	0.014	0.0001	0.400
P3	0.375	0.575	0.818	0.810
Side of epileptic activity
Right
P1	0.031	0.061	0.0001	0.754
Left
P1	0.017	0.007	0.0001	0.387
P4	0.781	0.392	0.966	0.626
CBZ
P1	0.068	0.001	0.0001	0.064
P5	0.239	0.546	0.682	0.739
P6	0.051	0.374	0.682	0.528
VPA
P1	0.009	0.007	0.0001	0.324
P6	0.170	0.628	0.698	0.867
Polytherapy
P1	0.007	0.243	0.0001	0.806
Controlled
P1	0.136	0.115	0.0001	0.208
P7	0.189	0.116	0.090	0.056
P8	0.185	0.174	0.528	0.683
Partially uncontrolled
P1	0.019	0.003	0.0001	0.542
P8	0.903	0.524	0.158	0.034
Uncontrolled
P1	0.012	0.001	0.0001	0.004

CBZ: Carbamazepine; VPA: Valproate; P1: Patients vs controls; P2: Generalized vs focal; P3: vs frontal; P4: Right vs left; P5: CBZ vs VPA; P6: vs polytherapy; P7: vs partially controlled; P8: vs uncontrolled.